Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib-Reference-Cited by-同舟云学术

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

Published:2011-08-24 Issue:8 Volume:34 Page:949-959
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Pinter M.,Sieghart W.,Hucke F.,Graziadei I.,Vogel W.,Maieron A.,Königsberg R.,Weissmann A.,Kornek G.,Matejka J.,Stauber R.,Buder R.,Grünberger B.,Schöniger-Hekele M.,Müller C.,Peck-Radosavljevic M.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2011.04823.x/fullpdf

Reference31 articles.

1. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis;Bruix;Lancet,1989

2. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection inJapan;Shiratori;Hepatology,1995

3. Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum;Burroughs;Lancet Oncol,2004

4. Updated treatment approach to hepatocellular carcinoma;Llovet;J Gastroenterol,2005

5. Prognosis of hepatocellular carcinoma: the BCLC staging classification;Llovet;Semin Liver Dis,1999

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers;Cancer and Metastasis Reviews;2023-02-02

2. Development and External Validation of the Munich Sorafenib Evaluation Score for Hepatocellular Carcinoma;Digestive Diseases;2022-04-14

3. Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization;Academic Radiology;2021-11

4. Systemic targeted and immunotherapy for advanced hepatocellular carcinoma;American Journal of Health-System Pharmacy;2020-11-19

5. Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database;Cancer Medicine;2020-06-11